A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.

Dopamine-beta-hydroxylase (D beta H) catalyzes the conversion of dopamine to norepinephrine and is released from sympathetic neurons into the circulation. Plasma-D beta H activity varies widely between individuals, and a subgroup of the population has very low activity levels. Mounting evidence suggests that the DBH structural gene is itself the major quantitative-trait locus (QTL) for plasma-D beta H activity, and a single unidentified polymorphism may account for a majority of the variation in activity levels. Through use of both sequencing-based mutational analysis of extreme phenotypes and genotype/phenotype correlations in samples from African American, European American (EA), and Japanese populations, we have identified a novel polymorphism (--1021C-->T), in the 5' flanking region of the DBH gene, that accounts for 35%--52% of the variation in plasma-D beta H activity in these populations. In EAs, homozygosity at the T allele predicted the very low D beta H-activity trait, and activity values in heterozygotes formed an intermediate distribution, indicating codominant inheritance. Our findings demonstrate that --1021C-->T is a major genetic marker for plasma-D beta H activity and provide new tools for investigation of the role of both D beta H and the DBH gene in human disease.

[1]  R. Glass,et al.  Plasma dopamine-beta-hydroxylase in depressed patients. , 1982, Biological psychiatry.

[2]  Walter L. Smith Probability and Statistics , 1959, Nature.

[3]  G. Sedvall,et al.  Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. , 1986, Journal of psychiatric research.

[4]  D. Cox,et al.  An Analysis of Transformations , 1964 .

[5]  T Nagatsu,et al.  Human dopamine beta-hydroxylase gene: two mRNA types having different 3'-terminal regions are produced through alternative polyadenylation. , 1989, Nucleic acids research.

[6]  Kazuto Kobayashi,et al.  Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation , 1998, Human Genetics.

[7]  N. Risch Searching for genetic determinants in the new millennium , 2000, Nature.

[8]  J. Mallet,et al.  The primary structure of human dopamine‐beta‐hydroxylase: insights into the relationship between the soluble and the membrane‐bound forms of the enzyme. , 1987, The EMBO journal.

[9]  R. Elston,et al.  Segregation and linkage analyses of dopamine-beta-hydroxylase activity. , 1979, Human heredity.

[10]  J. Phillips,et al.  Linkage analysis of the human dopamine beta-hydroxylase gene. , 1991, Genomics.

[11]  K. Kidd,et al.  Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). , 1997, American journal of medical genetics.

[12]  K. Kidd,et al.  Sequence tagged site (STS) TaqI RFLP at dopamine beta-hydroxylase (DBH). , 1991, Nucleic acids research.

[13]  R. Weinshilboum,et al.  Serum dopamine-beta-hydroxylase activity: sibling-sibling correlation. , 1973, Science.

[14]  K. Druschky,et al.  Differentiation of Parkinson’s disease and multiple system atrophy in early disease stages by means of I-123-MIBG–SPECT , 2000, Journal of the Neurological Sciences.

[15]  J. Gelernter,et al.  Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence. , 2000, American journal of medical genetics.

[16]  R. Weinshilboum,et al.  Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. , 1976, American journal of human genetics.

[17]  R. Mathew,et al.  Depression, antidepressants, and plasma DBH , 1981, Psychiatry Research.

[18]  J. Mallet,et al.  Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. , 1988, Cytogenetics and cell genetics.

[19]  R. Teradaira,et al.  SERUM DOPAMINE‐β‐HYDROXYLASE IN SCHIZOPHRENIC PATIENTS , 1978 .

[20]  M. Goldstein,et al.  SERUM DOPAMINE-β-HYDROXYLASE ACTIVITY IN PATIENTS WITH HUNTINGTON'S CHOREA AND PARKINSON'S DISEASE , 1972 .

[21]  R. Weinshilboum,et al.  Serum Dopamine-β-Hydroxylase Activity: Sibling-Sibling Correlation , 1973, Science.

[22]  N. Winer,et al.  Effect of cold pressor stimulation on plasma norepinephrine, dopamine-beta-hydroxylase, and renin activity. , 1977, Life sciences.

[23]  B. Müller-Oerlinghausen,et al.  Longitudinal assessment of MAO-, COMT-, and DBH- activity in patients with bipolar depression. , 1982, International pharmacopsychiatry.

[24]  K. Wakabayashi,et al.  Neuropathology of autonomic nervous system in Parkinson's disease. , 1997, European neurology.

[25]  R Imaizumi,et al.  Distribution of dopamine-beta-hydroxylase in subcellular fractions of adrenal medulla. , 1967, Life sciences.

[26]  T. Joh,et al.  Neuron-specific expression of the human dopamine beta-hydroxylase gene requires both the cAMP-response element and a silencer region. , 1993, The Journal of biological chemistry.

[27]  J. Phillips,et al.  Linkage analysis of the human dopamine β-hydroxylase gene , 1991 .

[28]  L. Wetterberg,et al.  Genetic control of plasma dopamine- β -hydroxylase , 1973 .

[29]  R. Weinshilboum,et al.  Inheritance of very low serum dopamine-beta-hydroxylase activity. , 1975, American journal of human genetics.

[30]  D. O'Connor,et al.  Immunocytochemical localization of dopamine-β-hydroxylase in neurons of the human brain stem , 1987, Neuroscience.

[31]  C. Ramchand,et al.  Possible control of dopamine β-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals , 1996, Human Genetics.

[32]  N. Shen,et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.

[33]  R. Weinshilboum Serum dopamine beta-hydroxylase. , 1978, Pharmacological reviews.

[34]  E. Mercer,et al.  Cell-specific expression from the human dopamine beta-hydroxylase promoter in transgenic mice is controlled via a combination of positive and negative regulatory elements , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  S. Daniel,et al.  Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease – a retrospective comparison , 1995, Acta neurologica Scandinavica.

[36]  O. H. Viveros,et al.  Release of catecholamines and dopamine-β-oxidase from the adrenal medulla , 1968 .

[37]  H. Meltzer,et al.  Serum dopamine-beta-hydroxylase activity in schizophrenia. , 1980, Biological psychiatry.

[38]  R. Elston,et al.  Segregation and Linkage Analyses of Dopamine-β-Hydroxylase Activity , 1979 .

[39]  J. Guilland,et al.  Plasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in man. , 1985, Medicine and science in sports and exercise.

[40]  T. Sellers,et al.  Stepwise oligogenic segregation and linkage analysis illustrated with dopamine-beta-hydroxylase activity. , 1990, American journal of medical genetics.

[41]  D. Murphy,et al.  Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity. , 1982, American journal of human genetics.

[42]  J. Brunet,et al.  Noradrenergic-Specific Transcription of the Dopamine β-Hydroxylase Gene Requires Synergy of MultipleCis-Acting Elements Including at Least Two Phox2a-Binding Sites , 1998, The Journal of Neuroscience.

[43]  R. Weinshilboum,et al.  Reduced plasma dopamine-beta-hydroxylase activity in familial dysautonomia. , 1971, The New England journal of medicine.

[44]  R. Weinshilboum,et al.  Serum Dopamine‐Beta‐Hydroxylase Activity , 1971, Circulation research.

[45]  Z. Rihmer,et al.  Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics. , 1983, Pharmacopsychiatria.

[46]  M. Goldstein,et al.  Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease. , 1972, Lancet.

[47]  R. Elston,et al.  Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. , 1988, American journal of human genetics.

[48]  J. Turkka,et al.  Serum noradrenaline response to standing up in patients with Parkinson's disease. , 1986, European neurology.

[49]  T. Kondo,et al.  Dopamine beta-hydroxylase activity in cerebrospinal fluid of Parkinsonian patients , 1982 .

[50]  L. Price,et al.  A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia , 2000, Molecular Psychiatry.